Lymphedema

Key points
- The underlying mechanism in lymphedema is impairment of the flow of lymph from an extremity.
- Lymphedema is a chronic disease for which there is no complete cure.
- When due to congenital developmental abnormalities consisting of hypo- or hyperplastic changes of the proximal or distal lymphatics, it is referred to as primary lymphedema.
- Familial lymphedema developing before 1 year of age is called Milroy's disease; it is usually bilateral and affects boys more often than girls.
Introduction
Essentials of Diagnosis
- Painless edema of upper or lower extremities.
- Involves the dorsal surfaces of the hands and fingers or the feet and toes.
- Developmental or acquired, unilateral or bilateral.
- Edema is pitting initially and becomes brawny and nonpitting with time.
- Ulceration, varicosities, and stasis pigmentation do not occur. There may be episodes of lymphangitis and cellulitis.
General Considerations
The underlying mechanism in lymphedema is impairment of the flow of lymph from an extremity. When due to congenital developmental abnormalities consisting of hypo- or hyperplastic changes of the proximal or distal lymphatics, it is referred to as primary lymphedema. Familial lymphedema developing before 1 year of age is called Milroy's disease; it is usually bilateral and affects boys more often than girls. Morecommonly, lymphedema develops during adolescence (lymphedema praecox) and is unilateral; there is a 3.5:1 female predominance. Lymphedema occurring after age 35 years is referred to as lymphedema tarda. The secondary form of lymphedema results from an inflammatory or mechanical obstruction of the lymphatics following trauma, regional lymph node resection, irradiation, bacterial or fungal infections, lymphoproliferative diseases, or filariasis.
Lymphatic obstruction results in stasis of a protein-rich fluid, with slowly progressive, painless edema and secondary fibrosis that may be exacerbated by superimposed episodes of acute infection. The edema is usually centered around the ankle and involves the toes and the dorsum of the foot. Hypertrophy of the limb results, with markedly thickened skin and subcutaneous tissue. Rarely, lymphangiosarcoma or angiosarcoma may develop as a complication of chronic lymphedema. This neoplastic transformation of blood vessels and lymphatics is called the Stewart-Treves syndrome.
Diagnosis is usually made on the basis of clinical findings. Venous duplex ultrasonography is performed to exclude venous insufficiency or vascular malformations. Lymphangiography and radioactive isotope studies are indicated only if surgical reconstruction is anticipated.
Treatment
Lymphedema is a chronic disease for which there is no complete cure. However, a variety of conservative measures can substantially reduce the risk of further complications and disability. No drug therapy is effective. Use of benzopyrones (eg, dicumarol) and corticosteroid injections to increase lymphatic transport has not shown consistent benefit. Diuretics can be useful for acute exacerbation of edema secondary to infection or for coexisting venous stasis disease but are not recommended for long-term use.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →
NewsSupercomputers listen to the heart
New supercomputer models have come closer than ever to capturing the behavior of normal human heart valves and their replacements, according to recent studies by groups including scientists at the Institute for…
20 August 2015
NewsJust 1 in 10 are referred for cardiac rehab after treatment for heart failure
Only 1 in 10 heart failure patients is referred to a cardiac rehabilitation program after being hospitalized, despite strong evidence that such exercise programs improve quality of life and reduce the likelihood of…
18 August 2015
NewsPredicting risk for deadly cardiac events
A marker commonly used to determine if a patient is having a heart attack can also be used to identify stable patients at high risk for deadly cardiac events, according to a new study led by investigators at Brigham and…
13 August 2015



